Stay updated with breaking news from Precigen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
HC Wainwright reaffirmed their buy rating on shares of Precigen (NASDAQ:PGEN – Free Report) in a report issued on Wednesday, Benzinga reports. HC Wainwright currently has a $6.00 price target on the biotechnology company’s stock. HC Wainwright also issued estimates for Precigen’s Q1 2024 earnings at ($0.09) EPS, Q2 2024 earnings at ($0.09) EPS, Q3 […]
With the business potentially at an important milestone, we thought we'd take a closer look at Precigen, Inc.'s...
Precigen (NASDAQ:PGEN – Get Free Report) was upgraded by research analysts at StockNews.com to a “sell” rating in a research note issued on Tuesday. Precigen Stock Performance NASDAQ PGEN opened at $1.38 on Tuesday. The company’s fifty day moving average is $1.30 and its two-hundred day moving average is $1.32. Precigen has a 52-week low […]
Precigen (NASDAQ:PGEN – Get Free Report) was upgraded by stock analysts at StockNews.com to a “sell” rating in a research report issued on Tuesday. Precigen Price Performance Shares of PGEN opened at $1.38 on Tuesday. The firm has a fifty day simple moving average of $1.30 and a two-hundred day simple moving average of $1.32. […]
Quite a few insiders have dramatically grown their holdings in Precigen, Inc. ( NASDAQ:PGEN ) over the past 12 months...